Skip to main content

View full-text article in PMC

. 2013 Jan 10;12:5. doi: 10.1186/2251-6581-12-5

Table 2.

Clinical and biological markers in the groups, regarding the severity of OSA

*Biomarkers*	Mild-to-moderate OSA (19)	Severe OSA (48)
Resistin, ng/ml	3.96±2.97	4.92±4.8
Resistin, ng/ml	3.96±2.97	p-0.362
Free fatty acids mmol/l	0.213±0.08	0.241±0.12
Free fatty acids mmol/l	0.213±0.08	p-0.375
Isoprostanes	0.089±0.07	0.088±0.08
Isoprostanes	0.089±0.07	p-0.985
*Lipid profiles*
High density Chol, mmol/l	1.37±0.21	1.23±0.32
High density Chol, mmol/l	1.37±0.21	p-0.821
Low density Chol, mmol/l	3.05±0.81	3.01±0.95
Low density Chol, mmol/l	3.05±0.81	p-0.872
Very low density Chol, mmol/l	0.84±0.36	0.83±0.43
Very low density Chol, mmol/l	0.84±0.36	p-0.952
Tot Chol, mmol/l	5.31±1.09	5.06±1.08
Tot Chol, mmol/l	5.31±1.09	p-0.405
Trigl, mmol/l	1.92±0.82	1.91±0.99
Trigl, mmol/l	1.92±0.82	p-0.786
*Insulin resistance*
Immunoreactive insulin, mU/L	20.47±10.06	26.31±24.5
Immunoreactive insulin, mU/L	20.47±10.06	p-0.470
HOMA index	5.04±3.69	6.35±6,45
HOMA index	5.04±3.69	p-0.586
HbA1C	6.32±0.9	6.31±1.09
HbA1C	6.32±0.9	p-0.681